Resource Type

[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants] (open access)

[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]

A news release from Burrough Wellcome Co. about their brand of zidovudine (AZT), Retrovir, being approved by the FDA to reduce the risk of HIV transmission from pregnant mothers to their infants.
Date: 1987
Creator: Burroughs Wellcome Co.
Object Type: Text
System: The UNT Digital Library
[Letter to Gloria Goodwin] (open access)

[Letter to Gloria Goodwin]

A letter from Gray Davis of Burrough Wellcome Co. to Gloria Goodwin discussing a zidovudine-acyclovir trial in the clinic where Goodwin works.
Date: September 1, 1989
Creator: Burroughs Wellcome Co.
Object Type: Letter
System: The UNT Digital Library